Trial Outcomes & Findings for MRI for Non-invasive Evaluation of Brain Stress (NCT NCT01898650)

NCT ID: NCT01898650

Last Updated: 2023-05-23

Results Overview

To be measured with both oxygen extraction fraction and arterial spin labeling to measure blood flow.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

12 participants

Primary outcome timeframe

during the single MRI scan, approximately 30 - 45 minutes

Results posted on

2023-05-23

Participant Flow

Patients were recruited from the beginning of 2013 (anticipated date) until September 2014 (anticipated date).

Participant milestones

Participant milestones
Measure
Craniofacial Abnormalities
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan. MR scan
Overall Study
STARTED
12
Overall Study
Scanned
11
Overall Study
COMPLETED
11
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Craniofacial Abnormalities
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan. MR scan
Overall Study
the subject would not lie still for imaging
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Craniofacial Abnormalities
n=12 Participants
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan. MR scan
Age, Categorical
<=18 years
12 Participants
n=12 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=12 Participants
Age, Categorical
>=65 years
0 Participants
n=12 Participants
Sex: Female, Male
Female
4 Participants
n=12 Participants
Sex: Female, Male
Male
8 Participants
n=12 Participants
Region of Enrollment
United States
12 Participants
n=12 Participants

PRIMARY outcome

Timeframe: during the single MRI scan, approximately 30 - 45 minutes

To be measured with both oxygen extraction fraction and arterial spin labeling to measure blood flow.

Outcome measures

Outcome measures
Measure
Craniofacial Abnormalities
n=6 Participants
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan. MR scan
Blood Flow and Perfusion
26.8 ml/min/100g
Standard Deviation 5.6

Adverse Events

Craniofacial Abnormalities

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Gary Skolnick

Washington University School of Medicine

Phone: 13144544005

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place